Literature DB >> 15322221

Cyclic adenosine 5'-monophosphate response element modulator is responsible for the decreased expression of c-fos and activator protein-1 binding in T cells from patients with systemic lupus erythematosus.

Vasileios C Kyttaris1, Yuang-Taung Juang, Klaus Tenbrock, Arthur Weinstein, George C Tsokos.   

Abstract

T cells from patients with systemic lupus erythematosus express increased levels of the cAMP response element modulator (CREM) that has been shown to bind to the IL-2 promoter and suppress its activity. In this study, we demonstrate that CREM binds to the proximal promoter of the c-fos proto-oncogene in live systemic lupus erythematosus T cells and represses its expression following stimulation in vitro. Decreased levels of c-fos protein result in decreased AP-1 activity, as determined in shift assays. Blockade of the translation of CREM mRNA with an antisense CREM vector increases the expression of c-fos and the AP-1 activity. The levels of c-fos mRNA vary with disease activity. We conclude that CREM represses the expression of c-fos and limits the activity of the enhancer AP-1. Thus, CREM is involved indirectly in the modulation of transcriptional regulation of multiple genes including IL-2.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15322221     DOI: 10.4049/jimmunol.173.5.3557

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

Review 1.  T cells as therapeutic targets in SLE.

Authors:  José C Crispín; Vasileios C Kyttaris; Cox Terhorst; George C Tsokos
Journal:  Nat Rev Rheumatol       Date:  2010-05-11       Impact factor: 20.543

2.  Prolonged expression of CD154 on CD4 T cells from pediatric lupus patients correlates with increased CD154 transcription, increased nuclear factor of activated T cell activity, and glomerulonephritis.

Authors:  Jay Mehta; Anna Genin; Michael Brunner; Lisabeth V Scalzi; Nilamadhab Mishra; Timothy Beukelman; Randy Q Cron
Journal:  Arthritis Rheum       Date:  2010-08

Review 3.  New insights into the pathogenesis of systemic lupus erythematosus.

Authors:  Vasileios C Kyttaris; Christina G Katsiari; Yuang-Taung Juang; George C Tsokos
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

4.  A novel intronic cAMP response element modulator (CREM) promoter is regulated by activator protein-1 (AP-1) and accounts for altered activation-induced CREM expression in T cells from patients with systemic lupus erythematosus.

Authors:  Thomas Rauen; Konrad Benedyk; Yuang-Taung Juang; Claus Kerkhoff; Vasileios C Kyttaris; Johannes Roth; George C Tsokos; Klaus Tenbrock
Journal:  J Biol Chem       Date:  2011-07-13       Impact factor: 5.157

5.  Transcriptional activation of the cAMP-responsive modulator promoter in human T cells is regulated by protein phosphatase 2A-mediated dephosphorylation of SP-1 and reflects disease activity in patients with systemic lupus erythematosus.

Authors:  Yuang-Taung Juang; Thomas Rauen; Ying Wang; Kunihiro Ichinose; Konrad Benedyk; Klaus Tenbrock; George C Tsokos
Journal:  J Biol Chem       Date:  2010-11-19       Impact factor: 5.157

Review 6.  T cells and IL-17 in lupus nephritis.

Authors:  Tomohiro Koga; Kunihiro Ichinose; George C Tsokos
Journal:  Clin Immunol       Date:  2016-04-21       Impact factor: 3.969

7.  The cyclic AMP response element modulator {alpha} suppresses CD86 expression and APC function.

Authors:  Martina Ahlmann; Georg Varga; Karsten Sturm; Ralph Lippe; Konrad Benedyk; Dorothee Viemann; Thomas Scholzen; Jan Ehrchen; Frank U Müller; Matthias Seidl; Marek Matus; George C Tsokos; Johannes Roth; Klaus Tenbrock
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

Review 8.  cAMP responsive element modulator: a critical regulator of cytokine production.

Authors:  Thomas Rauen; Christian M Hedrich; Klaus Tenbrock; George C Tsokos
Journal:  Trends Mol Med       Date:  2013-03-13       Impact factor: 11.951

Review 9.  Estrogen receptor signaling and its relationship to cytokines in systemic lupus erythematosus.

Authors:  E Kassi; P Moutsatsou
Journal:  J Biomed Biotechnol       Date:  2010-06-10

10.  Splicing factor SF2/ASF rescues IL-2 production in T cells from systemic lupus erythematosus patients by activating IL-2 transcription.

Authors:  Vaishali R Moulton; Alexandros P Grammatikos; Lisa M Fitzgerald; George C Tsokos
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.